Welcome to our dedicated page for Inverse VIX S/T Futs ETNs due Mar22,2045 SEC filings (Ticker: VYLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Inverse VIX S/T Futs ETNs due Mar22,2045's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Inverse VIX S/T Futs ETNs due Mar22,2045's regulatory disclosures and financial reporting.
JPMorgan Chase & Co director reports deferred stock award
A director of JPMorgan Chase & Co deferred a portion of their quarterly board retainer into company equity. On 12/31/2025, the director acquired 112.6694 shares of JPMorgan Chase common stock at a price of $322.22 per share, recorded as an acquisition rather than an open-market purchase.
After this transaction, the director beneficially owned a total of 13,726.3592 shares of JPMorgan Chase common stock, held directly. The filing explains that the award represents a deferral of the quarterly retainer that will be payable in common stock following the director’s termination of service.
JPMorgan Chase & Co. director reports deferred stock retainer
A director of JPMorgan Chase & Co. reported a Form 4 transaction dated 12/31/2025 involving company common stock. The filing shows an acquisition coded as “A(1),” with the footnote explaining this represents a deferral of the director’s quarterly cash retainer, which will be paid in common stock after the director’s service ends.
Following this transaction, the director beneficially owns 12,292.522 shares of JPMorgan Chase common stock held directly and 45 shares held indirectly through a spouse. The transaction reflects compensation taken in equity rather than cash, increasing the director’s reported ownership stake in the company.
JPMorgan Chase & Co. director activity shows a routine change in stock-based compensation. On 12/31/2025, a director acquired 139.6561 shares of common stock at
JPMorgan Chase & Co. director reports deferred stock compensation. A company director filed a report of a transaction dated 12/31/2025 showing acquisition of 174.5702 shares of JPMorgan Chase & Co. common stock at a price of $322.22 per share. The filing explains this represents a deferral of the director’s quarterly retainer, which will be paid in common stock following termination of service as a director.
After this transaction, the director beneficially owns 205,550.3435 shares directly and 55,245 shares indirectly through a Grantor Retained Annuity Trust. The filing notes that 19,755 shares were previously transferred from the trust to the grantor on 10/15/2025 under the trust’s terms, in a transaction described as exempt from Section 16 pursuant to Rule 16a-13.
JPMorgan Chase & Co. reported that Todd A. Combs has resigned from its Board of Directors, effective December 7, 2025. The company states that Mr. Combs’ resignation is not the result of any disagreement with JPMorgan Chase on any matter relating to its operations, policies, or practices. The filing also reiterates the company’s listed securities, including its common stock, multiple series of preferred stock depositary shares, and certain guaranteed notes and exchange-traded notes.
JPMorgan Chase & Co. (JPM) reported an insider transaction by a senior officer. On 11/12/2025, the Co‑CEO of CIB filed a Form 4 showing a bona fide gift of 9,500 shares of common stock (Transaction Code G) at $0.0000. After the transaction, the reporting person beneficially owned 141,626 shares directly, plus 91.4063 shares held indirectly via a 401(k).
JPMorgan Chase & Co. (JPM) insider transaction: The company’s Head of Human Resources reported a sale of common stock on 11/07/2025. The filing shows a sale (code S) of 966 shares at a price of $311.9162 per share.
Following this transaction, the reporting person holds 58,479 JPM shares directly. The filing also lists indirect holdings of 9,333 shares by a GRAT and 9,333 shares by the spouse’s GRAT. This is a personal share transaction and does not involve the company receiving proceeds.
JPMorgan Chase (JPM): Notice of proposed sale under Rule 144. A stockholder filed a Form 144 indicating an intent to sell 966 shares of Common Stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $301,311.06. The approximate sale date is 11/07/2025.
The shares were acquired on 01/13/2025 as equity compensation awards granted by the issuer. Shares outstanding were 2,722,262,295. Form 144 is a notice of a planned sale and does not itself execute the transaction.
JPMorgan Chase & Co. filed a Form 13F Holdings Report, detailing institutional equity holdings for the quarter. The filing lists a Form 13F Information Table Entry Total of 32,847 positions and a Form 13F Information Table Value Total of $1,669,071,139,042. The report includes 17 Other Included Managers across its investment platform. The report is signed by Michael T. Lees, Executive Director.
FAQ
What is the current stock price of Inverse VIX S/T Futs ETNs due Mar22,2045 (VYLD)?
